Evidence map›Paper›PMID 20091048›Full record

ReviewPflugers Archiv : European journal of physiology2010

Cardiac sodium channelopathies.

Ahmad S Amin, Alaleh Asghari-Roodsari, Hanno L Tan

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Pflugers Archiv : European journal of physiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03182777 (Safety of Local Dental Anesthesia in Patients With Cardiac Channelopathies), which is not on this map. Cited by 91 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 2 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03182777 nacompletednot on this mapstarted 2015, after this paper: background citation

Safety of Local Dental Anesthesia in Patients With Cardiac Channelopathies

TypeinterventionalSponsorUniversity of Sao Paulo General HospitalRan2015 to 2018Enrolled31ConditionsChannelopathies, Brugada Syndrome, Long QT Syndrome, Ventricular, TachycardiaArmsDental restorative procedure
3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 2 syntheses or guidelines pooled it, 211 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Multisite Validation of a Functional Assay to AdjudicateCirculation. Genomic and precision medicine · 2024
    Article
  13. Review
  14. Article
  15. Biophysical mechanisms of myocardium sodium channelopathies.Pflugers Archiv : European journal of physiology · 2024
    Review
  16. Article
  17. Multi-site validation of a functional assay to adjudicatemedRxiv : the preprint server for health sciences · 2023
    Article
  18. The opioid tramadol blocks the cardiac sodium channel Nav1.5 in HEK293 cells.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  19. [Asymptomatic channelopathies : Risk stratification and primary prophylaxis].Herzschrittmachertherapie & Elektrophysiologie · 2023
    Review
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ahmad S AminHeart Failure Research Center, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Alaleh Asghari-Roodsari
Hanno L Tan
University of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac sodium channel are protein complexes that are expressed in the sarcolemma of cardiomyocytes to carry a large inward depolarizing current (INa) during phase 0 of the cardiac action potential. The importance of INa for normal cardiac electrical activity is reflected by the high incidence of arrhythmias in cardiac sodium channelopathies, i.e., arrhythmogenic diseases in patients with mutations in SCN5A, the gene responsible for the pore-forming ion-conducting alpha-subunit, or in genes that encode the ancillary beta-subunits or regulatory proteins of the cardiac sodium channel. While clinical and genetic studies have laid the foundation for our understanding of cardiac sodium channelopathies by establishing links between arrhythmogenic diseases and mutations in genes that encode various subunits of the cardiac sodium channel, biophysical studies (particularly in heterologous expression systems and transgenic mouse models) have provided insights into the mechanisms by which INa dysfunction causes disease in such channelopathies. It is now recognized that mutations that increase INa delay cardiac repolarization, prolong action potential duration, and cause long QT syndrome, while mutations that reduce INa decrease cardiac excitability, reduce electrical conduction velocity, and induce Brugada syndrome, progressive cardiac conduction disease, sick sinus syndrome, or combinations thereof. Recently, mutation-induced INa dysfunction was also linked to dilated cardiomyopathy, atrial fibrillation, and sudden infant death syndrome. This review describes the structure and function of the cardiac sodium channel and its various subunits, summarizes major cardiac sodium channelopathies and the current knowledge concerning their genetic background and underlying molecular mechanisms, and discusses recent advances in the discovery of mutation-specific therapies in the management of these channelopathies.

Indexed as

AnimalsArrhythmias, CardiacBrugada SyndromeCardiomyopathy, DilatedChannelopathiesHeartHumansInfantLong QT SyndromeMuscle ProteinsMyocardiumMyocytes, CardiacNAV1.5 Voltage-Gated Sodium ChannelSick Sinus SyndromeSodium ChannelsSudden Infant DeathMuscle ProteinsNAV1.5 Voltage-Gated Sodium ChannelSCN5A protein, humanScn5a protein, mouseSodium Channels

Identifiers

PMID20091048
PMCPMC2883928
OpenAlexW2128208887

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.